[Form 4] Paysign, Inc. Insider Trading Activity
Paysign, Inc. insider Robert Strobo acquired 100,000 shares of restricted common stock on 05/07/2025 at a reported price of $0.00, increasing his beneficial ownership to 347,290 shares. The shares are restricted and will vest in three equal installments: one-third on May 27, 2026, one-third on May 24, 2027, and the final third on May 26, 2028, subject to Strobo's continued service to the company through each vesting date.
The Form 4 was signed by Robert Strobo on 09/26/2025 and identifies his role as Chief Legal Officer and as an officer reporting person. No derivative transactions, dispositions, exercise prices, or additional cash consideration are reported in this filing.
- Insider acquisition: Robert Strobo was granted 100,000 restricted shares, demonstrating management alignment with equity ownership.
- Clear vesting schedule: Shares vest one-third annually on specified dates in 2026, 2027, and 2028, supporting retention incentives.
- None.
Insights
TL;DR: Insider received 100,000 restricted shares that vest over three years, modestly increasing his stake to 347,290 shares.
The transaction is a non-cash grant of restricted common stock reported under Section 16. The award vests 1/3 annually across 2026-2028 contingent on continued service, indicating a retention-focused compensation element. The filing shows no sales or option exercises that would signal monetization. For investors, this is a standard executive equity grant; the filing does not disclose valuation beyond a $0.00 reported price, which reflects the nature of restricted stock grants rather than an open-market purchase.
TL;DR: The chief legal officer's restricted-share grant aligns executive incentives with shareholder interests through multi-year vesting.
This Form 4 documents a time-based equity award with clearly defined vesting dates, a common governance practice to promote retention and alignment. The increase to 347,290 shares is explicitly quantified and the vesting schedule is specified. The filing does not include performance conditions or accelerated vesting clauses, and it lacks details on grant rationale or board approval language, so assessment is limited to the disclosed mechanics of the award.